Search research articles
Contact Us
Filters
Showing results (91-100 of 99) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 99 results.
Transboundary and Emerging Diseases
|
June 24, 2025
Isolation and Characterization of Seneca Valley Virus From Pig Transboundary Spread to the Mink Infection
Ziliang Qin, Xinmiao He, Chao Chen, et al.
Scientific Reports
|
September 15, 2015
AlGaN/GaN Metal-Oxide-Semiconductor High-Electron-Mobility Transistor with Polarized P(VDF-TrFE) Ferroelectric Polymer Gating
Xinke Liu, Youming Lu, Wenjie Yu, et al.
Acta Ophthalmologica
|
November 27, 2023
Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study
Liqin Gao, Yanping Song, Xiaodong Sun, et al.
Oncotarget
|
October 4, 2017
miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinoma
Shaojun Chen, Longsheng Wang, Xudong Yao, et al.
BMC Women'S Health
|
March 8, 2017
Reproductive risk factors associated with breast cancer in women in Bangui: a case-control study
Augustin Balekouzou, Ping Yin, Christian Maucler Pamatika, et al.
Plos One
|
February 9, 2017
Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study
Augustin Balekouzou, Ping Yin, Henok Kessete Afewerky, et al.
The British Journal of Ophthalmology
|
May 18, 2021
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study
Kun Liu, Hanying Wang, Wei He, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Lang He, Mingqian Lu, et al.
Signal Transduction and Targeted Therapy
|
August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 99) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 99 results.
Transboundary and Emerging Diseases
|
June 24, 2025
Isolation and Characterization of Seneca Valley Virus From Pig Transboundary Spread to the Mink Infection
Ziliang Qin, Xinmiao He, Chao Chen, et al.
Scientific Reports
|
September 15, 2015
AlGaN/GaN Metal-Oxide-Semiconductor High-Electron-Mobility Transistor with Polarized P(VDF-TrFE) Ferroelectric Polymer Gating
Xinke Liu, Youming Lu, Wenjie Yu, et al.
Acta Ophthalmologica
|
November 27, 2023
Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study
Liqin Gao, Yanping Song, Xiaodong Sun, et al.
Oncotarget
|
October 4, 2017
miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinoma
Shaojun Chen, Longsheng Wang, Xudong Yao, et al.
BMC Women'S Health
|
March 8, 2017
Reproductive risk factors associated with breast cancer in women in Bangui: a case-control study
Augustin Balekouzou, Ping Yin, Christian Maucler Pamatika, et al.
Plos One
|
February 9, 2017
Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study
Augustin Balekouzou, Ping Yin, Henok Kessete Afewerky, et al.
The British Journal of Ophthalmology
|
May 18, 2021
Intravitreal conbercept for diabetic macular oedema: 2-year results from a randomised controlled trial and open-label extension study
Kun Liu, Hanying Wang, Wei He, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 12, 2026
Intravenous Patient-Controlled Analgesia Versus Oral Opioids to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase III Trial
Rongbo Lin, Lang He, Mingqian Lu, et al.
Signal Transduction and Targeted Therapy
|
August 6, 2025
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, et al.
Page
of 10